An antibiotic manufactured by Chapel Hill, N.C.-based Cempra has been rejected by the Food and Drug Administration, according to Reuters.
Supply Chain
The U.S. Food and Drug Administration on Dec. 27 issued a warning to healthcare professionals and administrators of the potential safety risks associated with battery-powered mobile medical carts following reports of explosions, fires, smoking or overheating of equipment.
The opioid overdose antidote naloxone — also known by its brand name Narcan — is now available without prescription at Missouri's two largest pharmacy chains, according to KSDK.
New York City-based Pfizer and Russia-based NovaMedica completed a long-term strategic partnership to transfer the rights and technologies for the production of more than 30 drugs from Pfizer's to NovaMedica's portfolio.
Former Turing Pharmaceuticals CEO Martin Shkreli gained notoriety in the healthcare industry for raising the price of Daraprim, a generic anti-parasite drug for treating toxoplasmosis, from $13.50 per pill to $750 overnight. Despite immense public pushback, Mr. Shkreli says he…
Advertisement
The U.S. Food and Drug Administration granted first-time approval to a drug designed to treat patients suffering from spinal muscular atrophy on Dec. 23.
The Food and Drug Administration is imposing a clinical hold on several of Seattle Genetics' early-stage studies involving an experimental cancer drug following the deaths of four people, Reuters reported.
3-D printing, also known as "additive manufacturing," has captured increasing mainstream interest, with new breakthroughs and applications being announced all the time. While it is revolutionizing the way certain products are manufactured, 3-D printing is poised to substantively benefit the…
Pharmaceutical companies that produce or distribute highly addictive pain medications have hired dozens of Drug Enforcement Administration officials over the past decade, a Washington Post investigation reveals.
Hospitals in Illinois' Lake County are running low on all types of blood and appointments with donors are too few in number, according to The Chicago Tribune.